1. Oral azole drugs as systemic antifungal therapy;Como;N Engl J Med,1994
2. Androgen receptor directed therapies in castration-resistant metastatic prostate cancer;Kim;Curr Treat Options Oncol,2012
3. Validity of diagnostic codes to identify cases of severe acute liver injury in the US Food and Drug Administration's Mini-Sentinel Distributed Database;Lo Re;Pharmacoepidemiol Drug Saf,2013
4. Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States;Chalasani;Gastroenterology,2008
5. European Medicines Agency. European Medicines Agency recommends suspension of marketing authorisations for oral ketoconazole. Benefit of oral ketoconazole does not outweigh risk of liver injury in fungal infections. EMA/458028/2013: 26 July 2013. Available at: www.ema.europa.eu/docs/en_GB/document_library/Press_release/2013/07/WC500146613.pdf. Accessed May 12, 2015.